consultant clinical oncologist with an interest in Breast lymphoma cancers

beatson west of scotland cancer centre


REF: 38804D

cLOSING DATE: Noon on 25th SEPTEMBER 2015


Post: consultant clinical oncologist with an with an interest in breast cancer and lymphoma

Base:beatson west of scotland cancer centre

The Beatson West of Scotland Cancer Centre (WoSCC), is seeking to appoint a Consultant Clinical Oncologist with specialist interests in Breast Cancer and Lymphoma. There will be an opportunity for successful applicants to negotiate different sub specialist interests post-appointment. Experience in the relevant subspecialties is not essential and relevant training will be extended to the successful applicant.

The new Beatson West of Scotland Cancer Centre (BWoSCC) opened in May 2007, completing a state of the art comprehensive cancer centre that has cost £110 million. It is Scotland’s largest cancer centre, and the second largest in the UK. The centre has undergone unprecedented investment and our clinical teams deliver oncology services to a catchment population of 2.9 million people across 4 Health Board areas. The centre is part of the CRUK virtual comprehensive cancer treatment and research centre which also includes the Beatson Institute for Cancer Research and Translational Research Centre. It incorporates the Regional Haemato-oncology Autologous Transplant Unit and the National Allogeneic Transplant Service for haematological malignancies.

The equipment in the new centre is state-of-the-art, and includes 11 linear accelerators with on board imaging, and incorporates Image Guided Radiotherapy (IGRT), IMRT, and Stereotactic Radiotherapy into our portfolio of available technologies. The centre has procured VMAT technology to more effectively deliver IMRT. A completely new brachytherapy unit and programme has been established in the new centre. A new satellite radiotherapy treatment centre is being built in nearby Lanarkshire and will open in 2015

The Beatson is an internationally renowned academic centre, with Professors of Medical Oncology, Gynaecological Oncology, Clinical Oncology, Translational Research and Surgical Oncology currently in post. Professor Karen Vousden leads a renowned CRUK core-funded program of research at the internationallycompetitive Beatson Institute for Cancer Research. The clinical and research institutions are part of the virtual Comprehensive cancer Research and Treatment Centre core funded by CRUK and NHS greater Glasgow and Clyde

In addition, the Beatson West of Scotland Cancer Centre Clinical Research Unit is the largest of its kind to be funded by Cancer Research UK. The unit offers support to all clinicians within the BWoSCC to initiate and conduct first-in man clinical trials. The unit has a large portfolio of Phase I-III studies across the range of cancer sub-specialties and has a particular interest in the development of new anti-cancer drugs, supported by designated staff and facilities for Phase I/Early Phase II clinical trials. The unit also houses Scotland’s first ever co-ordinating centre for the National Cancer Research Institute.

Glasgow has excellent schools, public transport and recreational facilities.

Applicants must have full GMC Registration, a licence to practise and be eligible for inclusion in the GMC Specialist Register. Those trained in the UK should have evidence of higher specialist training leading to CCT in Clinical Oncology or eligibility for specialist registration (CESR) or be within 6 months of confirmed entry from the date of interview. Non-UK applicants must demonstrate equivalent training.

For further details of the posts please contact:

The Clinical Director, Dr David Dodds +44 (0)141 301 7076, e-mail


Consultant Clinical Oncologist

In Breast Cancer and Lymphoma


Ref: 38804D




1.Brief description of the Beatson West of Scotland Cancer Centre

  1. Role of the Cancer Centre

3.The work of the Directorate/Department/Specialty

4.The job itself

5.Duties of the post

Clinical Commitments

Teaching, Management, Research and Audit

Study and Training Research Opportunities 7 6 Study and Training 6 Research Research Research Opportunities

Provisional Weekly Timetable

6.Arrangements to visit the Cancer Centre

  1. Person Specification Oncologist
  1. Terms & Conditions
  1. Further Information


Further Particulars of the Post of Consultant Oncologist

Based initially at Beatson West of Scotland Cancer Centre site with duties in NHS Greater Glasgow and Clyde.

1. Description of the Beatson West of Scotland Cancer Centre

The Beatson West of Scotland Cancer Centre (BWoSCC) is Scotland’s largest cancer centre, and the largest in the UK based on activity. The centre has undergone unprecedented capital and resource investment and our clinical teams are redesigning the way oncology services are delivered to a population of 2.9m people across four Health Board areas. It offers our team of professionals a truly state-of–the-art environment in which to practise and develop their skills.

An internationally-renowned teaching centre, the Cancer Centre incorporates the academic units of Medical Oncology, Radiation Oncology, Translational Research and Palliative Care. Glasgow is a large, lively and friendly city and a great place to make a home. The schools are excellent and many are local to the cancer centre. In addition it has excellent transport links to other parts of Scotland, the UK and beyond. The city was host to the Commonwealth Games in summer 2014.

  1. Role of the Cancer Centre

The role of the Cancer Centre is to deliver all non-surgical oncology services for residents of the West of Scotland on the basis that:

services meet equitably the assessed needs of the population served

a high quality service, integrated within the Cancer Centre and also with other cancer care providers, is provided

services provided compare favourably with those elsewhere in the UK and there is continual focus on improving care and treatment for patients

expenditure represents value for money

staff are valued and encouraged to maintain high standards of patient care through, for example, access to continuing professional development

clinical outcomes are monitored and are discussed in the context of clinical audit and clinical governance

research and development are encouraged

3.The Work of the Cancer Centre

The Beatson West of Scotland Cancer Centre provides specialist oncology services to 60% of the Scottish population. The centre sees over 10,000 new patients a year and over 70,000 return patients. Over 105,000 fractions of radiotherapy and 28,000 cycles of chemotherapy are given each year in the centre alone. The clinical teams also deliver medical cancer treatments in 13 local hospitals in partnership with local specialist cancer teams. The centre employs over 800 staff including 75 consultants in oncology and haematology. The annual budget of Specialist Oncology Services is over £100m.

The centre has 170 beds in 9 wards (3 Wards of 40 beds are for haemato-oncology). One of these wards runs as an 8 bedded Brachytherapy Unit and one as an 18 bed 5 day/week chemotherapy ward. There is also a large and busy Day Case Chemotherapy Unit comprising 36 treatment stations. The centre has a self contained Acute Oncology Assessment Unit staffed by Advanced Nurse Practitioners which provides unscheduled care for cancer patients on treatment. The centre has its own out-patient department and a large aseptic facility for cytotoxic reconstitution. The unit has an accredited gene therapy aseptic facility. Up to 10 appropriate patients are accommodated in a local hotel while they undergo radiotherapy. The Beatson West of Scotland Cancer Centre (BWoSCC) is superbly equipped with 11 linear accelerators, the majority of which incorporate facilities for VMAT and on-board imaging (OBI). These facilities have allowed a dynamic, “can-do” approach to the development of new treatment techniques. The centre has recently launched high intensity mode (24 Gy/min) VMAT for stereotactic intracranial radiosurgery and for lung stereotactic ablative radiotherapy (SABR), both firsts for the UK. In addition, VMAT has become a well established routine treatment for all radical head and neck, brain and prostate cancers.

We anticipate VMAT becoming the treatment of choice at the centre for most radical radiotherapy within the next 12 months. There are exciting programmes underway to establish the technique for gynaecological, colo-rectal, lung treatment and prostate SABR. Supporting these developments is an expanding IGRT programme with facilities for CBCT, 4DCT, on-site MRI and PET/CT. 4DCT imaging is offered routinely for lung, and, driven by local clinical interest, will shortly be introduced for pancreas and breast. Imaging is supported by 3 CT Simulators and 1 conventional simulator.

The centre has a generously equipped brachytherapy facility with dedicated theatre and 2 HDR treatment units. On-site MRI is used to facilitate image-guided brachytherapy for cervix. There is an established LDR seed programme for prostate.

There is excellent access to CT, CT-PET and MRI scanning facilities for radiation planning, both in the Cancer Centre and in the adjacent West of Scotland Pet Centre. A second CT-PET scanner has been installed in June 2011. The WestGlasgowHospitals and many of the District General Hospitals throughout the Region are equipped with digital communication links and can transmit CT scan images to the centre. There is excellent co-operation with the Regional Department of Clinical Physics and Bio-Engineering whose headquarters are at the Western Infirmary. The Radiotherapy Division is based in the Cancer Centre. A large program of research and development in radiation physics has been developed, including research fellows and research physicists. The Radiotherapy Research Group and its program are led by Professor Anthony Chalmers.

National services at the Cancer Centre include sarcoma, prostate brachytherapy, allogeneic stem cell transplantation, and ophthalmic oncology. The Cancer Centre offers the full range of evidence-based regional oncology services including CHART therapy for lung cancer.

The Cancer Centre is an internationally renowned academic centre, with Professors of Clinical Oncology, Translational Research and Gynaecological Oncology currently in post. Professor Karen Vousden heads the laboratories at the internationally renowned Beatson Institute for Cancer Research, located 3 miles from the centre. This initiative, developed in collaboration with Cancer Research UK, offers unrivalled opportunity for collaboration in basic cancer research. The Beatson Institute has undergone a £30 million redevelopment funded by Cancer Research UK and the University of Glasgow. A Translational Research Centre has recently been built on the Garscube Estate to complete a virtual comprehensive cancer research and treatment centre, given CRUK Centre status in 2011. The Cancer Sciences Division was 4th in the whole of the United Kingdom in the 2009 Research Assessment Evaluation

For the Cancer Centre as a whole, there are particularly close links with the academic departments in GlasgowUniversity of gynaecology, surgery, pathology, dermatology and ophthalmology. These involve several joint clinics as well as clinical research projects. Close links also exist with CaledonianUniversity (therapy radiography), StrathclydeUniversity and PaisleyUniversity (radiation physics).

In addition, the Clinical Research Facility at the BWOSCC is the largest of its kind to be funded by Cancer Research UK. It houses Scotland’s first ever co-ordinating centre for the National Cancer Research Institute. The unit offers support to all clinicians within the BWOSCC to initiate and conduct clinical trials. The unit has a large portfolio of Phase I - III studies across the range of cancer sub-specialties and has a particular interest in the development of first-in-man anti-cancer drugs. It is supported by designated staff and facilities for Phase I/early Phase II clinical trials. The trials unit has been rated alpha-star by external review. Already, at least 11% of the regional cancer centre’s patients are entered into clinical trials.

Clinics are held in eight hospitals within NHS Greater Glasgow & Clyde and in seven other board areas. Chemotherapy is prescribed and delivered in nine hospitals out with the city of Glasgow.

In 2013 the centre opened a new Acute Oncology Assessment Unit to provide on site specialist triage and assessment of cancer patients with unscheduled needs. Thus unit is staffed by 2 Advanced Nurse Practitioners and 4 senior triage nurses 8-8pm Monday to Friday.

4.The Job Itself

(a)Title:Consultant Clinical Oncologist

NHS Greater Glasgow & Clyde is the employing authority.

The Names of current consultant members of the Service are:

Clinical Oncology

Dr David Dodds (Clinical Director)

Dr Diana Ritchie Dr Diana Ritchie

Professor Anthony ChalmersDr Stefano Schipani

Dr Richard D JonesDr Azmat Sadoyze

Dr Fiona Cowie Dr Nick Reed

Dr Allan JamesDr Claire Paterson

Dr Rosemary StevensDr Nazia Mohammed

Dr Alec McDonaldDr Jan Wallace

Dr Carrie FeatherstoneDr Kathryn Graham

Dr Abdulla Alhasso Dr Aisling Hennessy

Dr Jonathan HicksDr David Macintosh

Dr Mohammed RizwanullahDr Vivienne MacLaren

Dr Rosie HarrandDr Graeme Lumsden

Dr Stephen HarrowDr Grainne Dunn

Dr Norma SidekDr Carolynn Lamb

Dr Brian ClarkDr Derek Grose

Dr Noelle O’RourkeDr Nick MacLeod

Medical Oncology

Dr David Dunlop (Chief of Medicine) Dr Ros Glasspool

Dr Rob Jones Dr Hilary Glen

Professor T R Jeff Evans Dr Iain Macpherson

Dr Jeff WhiteDr Sophie Barrett

Dr Judy Fraser Dr Lucy Scott

Dr Ashita WaterstonDr Nicola Steele

Dr Clinton AliDr Janet Graham

Dr Dawn StoreyProf. Iain McNeish

Dr Balaji Venugopal

Palliative Medicine

Dr Alison MitchellDr Helen Morrison

Dr Jane Edgecombe

Number and Grades of Junior Medical Staff

“Specialist Registrars” 19 in Clinical Oncology + 5 in Medical Oncology

“Senior House Officers” 15

Associate Specialist in Oncology 1

Speciality Doctors 5

Departmental Organisation

In order to facilitate medical management the BWOSCC is divided into 6 teams

for specialist oncology services based on the following tumour sites:





Head & Neck (& neuro-oncology)

Gynaecology (including neuro endocrine and sarcoma)

All wards within the BWOSCC (with the exception of brachytherapy) are allocated to the teams and have integrated medical and clinical oncology stakeholders. There are 2 Consultant on-call rotas, one for Medical Oncology and one for Clinical Oncology. On call commitments take priority over scheduled commitments when consultant on call. The unit participates in the GGHcampusHospital at Night programme of out of hours care. The BWOSCC is committed to multi-disciplinary team working and the Cancer Managed Clinical Networks for the West of Scotland.

Each team has a trainer who supervises the trainees. Clinical and Educational Supervision is provided to trainees in conjunction with the local Deanery. The teams are headed by a team leader who is responsible for the development of departmental medical protocols, absence management and team deployments.

All consultants participate in care delivered by multidisciplinary cancer site specific teams consisting of Specialty Doctors, Clinical Nurse Specialists, IV Nurses, Pharmacists and Phlebotomists. All beds are shared and managed by a Bed Management Team who arranges admissions on the basis of need. The centre has a 6 bedded state of the art, age appropriate Teenage and Adolescent Unit which is used by patients between the ages of 16 and 25 with solid and haematological cancers.

5.Duties of the Post

Clinical Commitments:

This is a replacement consultant appointment. The successful applicant will take up a post providing specialist oncology input into Breast Cancer and Lymphoma services in Glasgow and the West Region, (with Dr Sophie Barrett in Breast and Dr.Noelle ORourke/Dr.Carrie Featherstone in Lymphoma).These services are mature, developed and supported by teams of existing consultant clinical and medical oncologists. These practices involve participation in well organised and supported site specific MDTs locally for both tumour sites.

A proposed timetable for the post is detailed below. Note that this post is for a commitment of 10 sessions (PAs) initially. Most consultant posts with significant peripheral commitments will generally attract an additional PA for travel time. The number of PAs can vary with service activity and is agreed through the job planning process.

Monday AM / am / Ward round/SPA/Clinical Admin
pm / Radiotherapy voluming
Tuesday / am / SPA
pm / Lymphoma clinic/MDT
Wed / am / Breast clinic BOC/MDT
pm / Stobhill breast clinic
Thursday / am / GRI/Stobhill Breast/MDT
pm / Breast OP clinic
Friday / am / Radiotherapy simulator/plan review and prescription/Breast Team meeting
pm / Departmental Teaching/SPA

This job plan is negotiable and will be agreed between the successful applicant and the Clinical Director. NHS Greater Glasgow & Clyde initially allocates all full time consultants 10 PAs made up of 9 PAs in Direct Clinical Care (DCC) and one core Supporting Professional Activities (SPA) for CPD, audit, clinical governance, appraisal, revalidation, job planning, internal routine communication and management meetings. The precise allocation of SPA time and associate objectives will be agreed with the successful applicant and will be reviewed at annual job planning.

Radiotherapy is delivered in the Beatson West of Scotland Cancer Centre. There will be an option for remote radiotherapy planning from Glasgow to deliver therapy at new satellite centre in Monklands Hospital for Lanarkshire patients although it is not thought that this facility will be necessary to the successful applicant in the first place.

Cross cover is provided by named colleagues. Note that the post holder works as part of a team to manage cross cover for clinics and radiotherapy planning. It is anticipated that the successful applicant will be a member of the Breast and Lung cancer teams.

The on call frequency is 1 week on call in 28. When on call the consultant is expected to reduce/cancel scheduled clinical activities to participate in on call duties and the review of unscheduled admissions